NICE recommends new treatment to prevent and reduce hearing loss in people being treated for cancer

NICE

20 December 2024 - For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing.

Cisplatin is a powerful chemotherapy medicine which is routinely used to treat many cancers in children. Over time, cisplatin builds up in the inner ear and can cause inflammation and damage, known as ototoxicity, which is a cause of hearing loss.

Read NICE press release 

Michael Wonder

Posted by:

Michael Wonder